MYDAYIS (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the MYDAYIS drug offered from Shire US Manufacturing Inc.. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
| NON-PROPRIETARY NAME: | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE |
| SUBSTANCE NAME: | DEXTROAMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-06-20 |
| END MARKETING DATE: | 0000-00-00 |
MYDAYIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | MYDAYIS from Shire US Manufacturing Inc. |
| LABELER NAME: | Shire US Manufacturing Inc. |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 3.125; 3.125; 3.125; 3.125(mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2017-06-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54092-468_0cd3141a-6177-4360-859e-eefd7cdd0eee |
| PRODUCT NDC: | 54092-468 |
| APPLICATION NUMBER: | NDA022063 |
Other DEXTROAMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
